Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging

Journal of Neural Transmission

Volumn 123, Issue 3, 2016, Pages 281-287

  Hübers, Annemarie ^a   Müller, Hans Peter ^a   Dreyhaupt, Jens ^a   Böhm, Kathrin ^a   Lauda, Florian ^a   Tumani, Hayrettin ^a   Kassubek, Jan ^a   Ludolph, Albert C ^a   Pinkhardt, Elmar H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Neurodegeneration; Optical coherence tomography; Retina; Technical biomarker

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL DEGENERATION; NUCLEAR MAGNETIC RESONANCE SCANNER; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHENOTYPE; PRIORITY JOURNAL; RETINA; RETINA DISEASE; RETINA INNER NUCLEAR LAYER; RETINA INNER PLEXIFORM LAYER; RETINA OUTER PLEXIFORM LAYER; RETINAL NERVE FIBER LAYER THICKNESS; COMPUTER ASSISTED DIAGNOSIS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84959093371     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-015-1483-4     Document Type: Article

References (39)

1. Agosta F, Chio A, Cosottini M et al (2010a) The present and the future of neuroimaging in amyotrophic lateral sclerosis. Am J Neuroradiol 31:1769–1777. doi:10.3174/ajnr.A2043
2. Agosta F, Pagani E, Petrolini M et al (2010b) Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. Am J Neuroradiol 31:1457–1461. doi:10.3174/ajnr.A2105
3. Agosta F, Weiler M, Filippi M (2015) Propagation of pathology through brain networks in neurodegenerative diseases: from molecules to clinical phenotypes. CNS Neurosci Ther n/a–n/a. doi:10.1111/cns.12410
4. Boycott B, Wassle H (1999) Parallel processing in the mammalian retina: the Proctor Lecture. Invest Ophthalmol Vis Sci 40:1313–1327
5. Brett M, Johnsrude IS, Owen AM (2002) The problem of functional localization in the human brain. Nat Rev Neurosci 3(3):243–249
6. Brettschneider J, Del Tredici K, Toledo JB et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20–38. doi:10.1002/ana.23937
7. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299
8. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1–2):13–21
9. Chio A, Pagani M, Agosta F et al (2014) Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol 13:1228–1240. doi:10.1016/S1474-4422(14)70167-X
10. Eisen A, Weber M (2000) Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 1(Suppl 1):S47–S51
11. Fawzi AA, Simonett JM, Purta P et al (2014) Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation. Amyotroph Lateral Scler Frontotemporal Degener. doi:10.3109/21678421.2014.951941
12. Foerster BR, Callaghan BC, Petrou M et al (2012) Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 78:1596–1600. doi:10.1212/WNL.0b013e3182563b57
13. Foerster BR, Dwamena BA, Petrou M et al (2013a) Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol 20:1099–1106. doi:10.1016/j.acra.2013.03.017
14. Foerster BR, Pomper MG, Callaghan BC et al (2013b) An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA neurology 70:1009–1016. doi:10.1001/jamaneurol.2013.234
15. Geevasinga N, Menon P, Howells J et al (2015) Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis. JAMA Neurol 72:49–57. doi:10.1001/jamaneurol.2014.2940
16. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15:870–878. doi:10.1006/nimg.2001.1037
17. Kassubek J, Müller H-P, Del Tredici K et al (2014) Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain J Neurol 137:1733–1740. doi:10.1093/brain/awu090
18. Kesler A, Vakhapova V, Korczyn AD et al (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin Neurol Neurosurg 113:523–526. doi:10.1016/j.clineuro.2011.02.014
19. Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955. doi:10.1016/S0140-6736(10)61156-7
20. Kunimatsu A, Aoki S, Masutani Y et al (2004) The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn Reson Med Sci 3:11–17
21. London A, Benhar I, Schwartz M (2013) The retina as a window to the brain-from eye research to CNS disorders. Nature Rev Neurol 9:44–53. doi:10.1038/nrneurol.2012.227
22. Lulé D, Burkhardt C, Abdulla S et al (2014) The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. doi:10.3109/21678421.2014.959451
23. MacNeil MA, Masland RH (1998) Extreme diversity among amacrine cells: implications for function. Neuron 20:971–982
24. Moss HE, McCluskey L, Elman L et al (2012) Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 314:97–101. doi:10.1016/j.jns.2011.10.016
25. Müller H-P, Kassubek J (2013) Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. J Vis Exp. doi:10.3791/50427
26. Muller HP, Unrath A, Ludolph AC, Kassubek J (2007) Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol 52:N99–N109. doi:10.1088/0031-9155/52/6/N01
27. Müller A-K, Blasberg C, Südmeyer M et al (2014) Photoreceptor layer thinning in parkinsonian syndromes. Mov Disord 29:1222–1223. doi:10.1002/mds.25939
28. Nubling GS, Mie E, Bauer RM et al (2014) Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:174–179. doi:10.3109/21678421.2013.868001
29. Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83:102–108. doi:10.1136/jnnp-2011-300188
30. Ringelstein M, Albrecht P, Südmeyer M et al (2014) Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Trans Neurol 1:290–297. doi:10.1002/acn3.46
31. Roth NM, Saidha S, Zimmermann H et al (2013) Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Euro J Neurol Off J Euro Federat Neurol Societ 20:1170–1176. doi:10.1111/ene.12146
32. Schneider M, Müller H-P, Lauda F et al (2014) Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. Journal of neural transmission (Vienna, Austria: 1996) 121:41–47. doi:10.1007/s00702-013-1072-3
33. Sharma R, Hicks S, Berna CM et al (2011) Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol 68:857–861. doi:10.1001/archneurol.2011.130
34. Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One 7:e34823–e34827. doi:10.1371/journal.pone.0034823
35. Turner MR, Kiernan MC (2012) Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 13:245–250. doi:10.3109/17482968.2011.636050
36. Turner MR, Modo M (2010) Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn 4:483–496. doi:10.1517/17530059.2010.536836
37. Vucic S, Cheah BC, Kiernan MC (2009) Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol 220:177–182. doi:10.1016/j.expneurol.2009.08.017
38. Wassle H (2004) Parallel processing in the mammalian retina. Nat Rev Neurosci 5:747–757. doi:10.1038/nrn1497
39. Weis J, Katona I, Muller-Newen G et al (2011) Small-fiber neuropathy in patients with ALS. Neurology 76:2024–2029. doi:10.1212/WNL.0b013e31821e553a